Elijah J. Weber

803 total citations
12 papers, 610 citations indexed

About

Elijah J. Weber is a scholar working on Molecular Biology, Epidemiology and Biomedical Engineering. According to data from OpenAlex, Elijah J. Weber has authored 12 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Epidemiology and 4 papers in Biomedical Engineering. Recurrent topics in Elijah J. Weber's work include Liver Disease Diagnosis and Treatment (4 papers), 3D Printing in Biomedical Research (4 papers) and Pluripotent Stem Cells Research (3 papers). Elijah J. Weber is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), 3D Printing in Biomedical Research (4 papers) and Pluripotent Stem Cells Research (3 papers). Elijah J. Weber collaborates with scholars based in United States, Czechia and Finland. Elijah J. Weber's co-authors include Edward J. Kelly, Jonathan Himmelfarb, Alenka Chapron, Danny D. Shen, Catherine K. Yeung, Thomas Neumann, Kevin A. Lidberg, Yoshiyuki Yamaura, Kimberly A. Muczynski and Zhican Wang and has published in prestigious journals such as Scientific Reports, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Elijah J. Weber

11 papers receiving 594 citations

Peers

Elijah J. Weber

NEPHR

PHARM

SURGE

Alenka Chapron United States

Brian D. Chapron United States

Katja Jansen Netherlands

Git Chung United Kingdom

Chen Xuan China

Miyuki Ito Japan

Ran Dong China

Taotao Zhang China

Yimeng Fan China

Xiaoyong Lu China

Alenka Chapron United States

Elijah J. Weber

218 ×0.6

160 ×0.6

52 ×0.7

NEPHR

81 ×1.1

PHARM

40 ×0.7

SURGE

Citations per year, relative to Elijah J. Weber Elijah J. Weber (= 1×) peers Alenka Chapron

Countries citing papers authored by Elijah J. Weber

Since Specialization

Citations

This map shows the geographic impact of Elijah J. Weber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elijah J. Weber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elijah J. Weber more than expected).

Fields of papers citing papers by Elijah J. Weber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elijah J. Weber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elijah J. Weber. The network helps show where Elijah J. Weber may publish in the future.

Co-authorship network of co-authors of Elijah J. Weber

This figure shows the co-authorship network connecting the top 25 collaborators of Elijah J. Weber. A scholar is included among the top collaborators of Elijah J. Weber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elijah J. Weber. Elijah J. Weber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Younis, Islam R., Elijah J. Weber, Cara R. Nelson, et al.. (2025). Pharmacokinetics and Safety of Fenofibrate in Participants with Mild Hepatic Impairment or with Advanced Fibrosis due to Metabolic‐Associated Fatty Liver Disease. The Journal of Clinical Pharmacology. 65(7). 850–859.

Younis, Islam R., Cara Nelson, Elijah J. Weber, et al.. (2024). Pharmacokinetics and Safety of Firsocostat, an Acetyl‐Coenzyme A Carboxylase Inhibitor, in Participants with Mild, Moderate, and Severe Hepatic Impairment. The Journal of Clinical Pharmacology. 64(7). 878–886. 2 indexed citations

Weber, Elijah J., Islam R. Younis, Cara Nelson, et al.. (2024). Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug–Drug Interactions for Firsocostat, a Liver-Targeted Inhibitor of Acetyl-CoA Carboxylase. Clinical Pharmacokinetics. 63(10). 1423–1434. 3 indexed citations

Younis, Islam R., Cara R. Nelson, Elijah J. Weber, et al.. (2024). Pharmacokinetics and Safety of Cilofexor and Firsocostat in Healthy Japanese and Non‐Japanese Participants. The Journal of Clinical Pharmacology. 64(12). 1586–1593. 2 indexed citations

Sakolish, Courtney, Elijah J. Weber, Edward J. Kelly, et al.. (2018). Technology Transfer of the Microphysiological Systems: A Case Study of the Human Proximal Tubule Tissue Chip. Scientific Reports. 8(1). 14882–14882. 65 indexed citations

Weber, Elijah J., Kevin A. Lidberg, Lu Wang, et al.. (2018). Human kidney on a chip assessment of polymyxin antibiotic nephrotoxicity. JCI Insight. 3(24). 70 indexed citations

Monteiro, Maria Beatriz, Susanne Ramm, Vidya Chandrasekaran, et al.. (2018). A High-Throughput Screen Identifies DYRK1A Inhibitor ID-8 that Stimulates Human Kidney Tubular Epithelial Cell Proliferation. Journal of the American Society of Nephrology. 29(12). 2820–2833. 8 indexed citations

Chang, Shih‐Yu, Elijah J. Weber, Viktoriya S. Sidorenko, et al.. (2017). Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity. JCI Insight. 2(22). 138 indexed citations

Weber, Elijah J., Jonathan Himmelfarb, & Edward J. Kelly. (2017). Concise review: Current and emerging biomarkers of nephrotoxicity. Current Opinion in Toxicology. 4. 16–21. 16 indexed citations

10.

Ness, Kirk P. Van, et al.. (2017). Microphysiological Systems to Assess Nonclinical Toxicity. Current Protocols in Toxicology. 73(1). 14.18.1–14.18.28. 20 indexed citations

11.

Weber, Elijah J., Alenka Chapron, Brian D. Chapron, et al.. (2016). Development of a microphysiological model of human kidney proximal tubule function. Kidney International. 90(3). 627–637. 191 indexed citations

12.

Adler, Melanie, Susanne Ramm, Marc Hafner, et al.. (2015). A Quantitative Approach to Screen for Nephrotoxic Compounds In Vitro. Journal of the American Society of Nephrology. 27(4). 1015–1028. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact